In fact, decreased PLAT activity, due to increased PAI-1 levels, impairs the capacity of PLAT to clear the fibrinogen deposits (fibrinolysis), at sites of BBB breakdown, demyelinated axons, and inflammatory MS lesions, therefore contributing to axonal damage [63,64]. This evidence concerns the gene SERPINE1 and myeloid sarcoma.